生长因子受体-话题@MedSci - 梅斯（MedSci）

#生长因子受体#

22篇内容 | 1657人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1776028, encodeId=9e2e1e76028d6, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=JAMA Oncol：抗表皮生长因子受体抗体药物偶联物MRG003治疗晚期实体瘤, objectType=article, longId=727924, objectId=0dbbe2792428, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0dbbe2792428, replyNumber=0, likeNumber=100, createdTime=2022-10-05, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0dbbe2792428, moduleTitle=JAMA Oncol：抗表皮生长因子受体抗体药物偶联物MRG003治疗晚期实体瘤, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0dbbe2792428)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776027, encodeId=43ae1e76027df, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=Front Oncol：左侧RAS/BRAF野生型转移性结直肠癌(mCRC)患者一线抗表皮生长因子受体(EGFR)为基础治疗后后续维持治疗管理, objectType=article, longId=219570, objectId=1d282195e0e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d282195e0e7, replyNumber=0, likeNumber=131, createdTime=2022-10-16, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d282195e0e7, moduleTitle=Front Oncol：左侧RAS/BRAF野生型转移性结直肠癌(mCRC)患者一线抗表皮生长因子受体(EGFR)为基础治疗后后续维持治疗管理, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1d282195e0e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776026, encodeId=fa7e1e76026c7, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=Eur Urol：继发于选择性成纤维细胞生长因子受体1-3抑制剂Infigratinib（BGJ398）的高磷血症与成纤维细胞生长因子受体3变异的晚期/转移性尿路癌的抗肿瘤疗效有关 , objectType=article, longId=200106, objectId=c2aa200106d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2aa200106d4, replyNumber=0, likeNumber=90, createdTime=2021-06-22, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2aa200106d4, moduleTitle=Eur Urol：继发于选择性成纤维细胞生长因子受体1-3抑制剂Infigratinib（BGJ398）的高磷血症与成纤维细胞生长因子受体3变异的晚期/转移性尿路癌的抗肿瘤疗效有关 , moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c2aa200106d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776023, encodeId=c1c31e76023c3, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=Breast Cancer Res Treat：Palbociclib加来曲唑作为雌激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌的一线治疗效果, objectType=article, longId=195894, objectId=347c195894a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=347c195894a4, replyNumber=0, likeNumber=100, createdTime=2020-07-22, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=347c195894a4, moduleTitle=Breast Cancer Res Treat：Palbociclib加来曲唑作为雌激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌的一线治疗效果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=347c195894a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776022, encodeId=387d1e760229b, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=成纤维细胞生长因子受体（FGFR）抑制剂pemigatinib治疗胆管癌获得FDA的优先审查, objectType=article, longId=184090, objectId=d0cc1840903e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0cc1840903e, replyNumber=0, likeNumber=74, createdTime=2020-05-01, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0cc1840903e, moduleTitle=成纤维细胞生长因子受体（FGFR）抑制剂pemigatinib治疗胆管癌获得FDA的优先审查, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d0cc1840903e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776025, encodeId=2efd1e7602521, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关, objectType=article, longId=199985, objectId=72b119998516, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72b119998516, replyNumber=0, likeNumber=77, createdTime=2021-03-09, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72b119998516, moduleTitle=Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=72b119998516)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776024, encodeId=dfcc1e7602436, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=J Clin Oncol：辅助紫杉醇和曲妥珠单抗试验治疗结节阴性、人表皮生长因子受体2阳性乳腺癌的七年随访分析, objectType=article, longId=195901, objectId=b90719590192, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b90719590192, replyNumber=0, likeNumber=79, createdTime=2020-08-18, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b90719590192, moduleTitle=J Clin Oncol：辅助紫杉醇和曲妥珠单抗试验治疗结节阴性、人表皮生长因子受体2阳性乳腺癌的七年随访分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b90719590192)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776021, encodeId=89301e7602195, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=Nat Commun：揭示胰岛素样生长因子受体IGF1R激活的分子机制, objectType=article, longId=181090, objectId=597018109021, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=597018109021, replyNumber=0, likeNumber=76, createdTime=2019-11-22, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=597018109021, moduleTitle=Nat Commun：揭示胰岛素样生长因子受体IGF1R激活的分子机制, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=597018109021)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776020, encodeId=5d7d1e76020d4, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=成纤维细胞生长因子受体酪氨酸激酶抑制剂E7090治疗胆管癌，获得日本厚生劳动省的Sakigake指定, objectType=article, longId=163899, objectId=93891638993f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93891638993f, replyNumber=0, likeNumber=80, createdTime=2019-11-18, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93891638993f, moduleTitle=成纤维细胞生长因子受体酪氨酸激酶抑制剂E7090治疗胆管癌，获得日本厚生劳动省的Sakigake指定, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=93891638993f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776018, encodeId=99421e76018a5, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=2019 CAP指南：乳腺癌人表皮生长因子受体2免疫组化定量分析, objectType=article, longId=159143, objectId=231c15914303, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=231c15914303, replyNumber=0, likeNumber=86, createdTime=2019-10-20, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=231c15914303, moduleTitle=2019 CAP指南：乳腺癌人表皮生长因子受体2免疫组化定量分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=231c15914303)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776019, encodeId=b63f1e7601977, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=Sci Rep：膀胱癌中组合光免疫疗法（PIT）靶向上皮生长因子受体（EGFR）和人类上皮生长因子受体2（HER2）研究, objectType=article, longId=161567, objectId=a15116156e8b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a15116156e8b, replyNumber=0, likeNumber=95, createdTime=2019-08-04, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a15116156e8b, moduleTitle=Sci Rep：膀胱癌中组合光免疫疗法（PIT）靶向上皮生长因子受体（EGFR）和人类上皮生长因子受体2（HER2）研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a15116156e8b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776016, encodeId=35f81e760168e, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=Hepatology：肝星状细胞来源的血小板衍生生长因子受体α-丰富的细胞外小泡通过SHP2促进小鼠肝纤维化, objectType=article, longId=145335, objectId=475714533599, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=475714533599, replyNumber=0, likeNumber=86, createdTime=2018-09-02, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=475714533599, moduleTitle=Hepatology：肝星状细胞来源的血小板衍生生长因子受体α-丰富的细胞外小泡通过SHP2促进小鼠肝纤维化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=475714533599)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776017, encodeId=c10f1e76017ce, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=J Biol Chem：异位成纤维细胞生长因子受体1在前列腺癌细胞中能够促进炎症, objectType=article, longId=146933, objectId=2e12146933de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e12146933de, replyNumber=0, likeNumber=88, createdTime=2019-06-22, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e12146933de, moduleTitle=J Biol Chem：异位成纤维细胞生长因子受体1在前列腺癌细胞中能够促进炎症, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2e12146933de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776015, encodeId=951d1e7601557, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=Diabetes：抑制肾上皮生长因子受体激活可延缓2型糖尿病肾病进展、改善胰岛素灵敏度, objectType=article, longId=142803, objectId=dd9a142803e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd9a142803e8, replyNumber=0, likeNumber=84, createdTime=2018-12-16, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd9a142803e8, moduleTitle=Diabetes：抑制肾上皮生长因子受体激活可延缓2型糖尿病肾病进展、改善胰岛素灵敏度, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=dd9a142803e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776012, encodeId=53221e760125b, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=Oncotarget：在预测TIG3膀胱癌结果中，人类表皮生长因子受体2表达比卡介苗处理更为重要, objectType=article, longId=97631, objectId=99059e63151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99059e63151, replyNumber=0, likeNumber=91, createdTime=2018-01-22, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99059e63151, moduleTitle=Oncotarget：在预测TIG3膀胱癌结果中，人类表皮生长因子受体2表达比卡介苗处理更为重要, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=99059e63151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776014, encodeId=4dee1e7601462, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=Ophthalmologica：糖尿病黄斑水肿患者的眼房水中可溶性血管内皮生长因子受体(sVEGFR)和炎症因子的水平显著高于非糖尿病人！, objectType=article, longId=100470, objectId=3fb01004e068, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fb01004e068, replyNumber=0, likeNumber=74, createdTime=2018-01-06, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fb01004e068, moduleTitle=Ophthalmologica：糖尿病黄斑水肿患者的眼房水中可溶性血管内皮生长因子受体(sVEGFR)和炎症因子的水平显著高于非糖尿病人！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3fb01004e068)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776013, encodeId=e7c51e7601387, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=Gut：表皮生长因子受体抑制剂对幽门螺杆菌诱导上皮细胞炎症、DNA损伤及胃癌的预防, objectType=article, longId=97962, objectId=3a689e962e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a689e962e2, replyNumber=0, likeNumber=74, createdTime=2018-01-09, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a689e962e2, moduleTitle=Gut：表皮生长因子受体抑制剂对幽门螺杆菌诱导上皮细胞炎症、DNA损伤及胃癌的预防, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3a689e962e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776011, encodeId=07271e7601135, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=2016EAU指南——血管内皮生长因子受体抵抗的肾脏透明细胞癌的靶向治疗发布, objectType=article, longId=79519, objectId=e5e8e951937, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5e8e951937, replyNumber=0, likeNumber=80, createdTime=2017-04-12, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5e8e951937, moduleTitle=2016EAU指南——血管内皮生长因子受体抵抗的肾脏透明细胞癌的靶向治疗发布, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e5e8e951937)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776010, encodeId=3db91e76010d9, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=2015中国表皮生长因子受体基因敏感性突变和间变淋巴瘤激酶融合基因阳性非小细胞肺癌诊断治疗指南发布, objectType=article, longId=77551, objectId=078de755107, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=078de755107, replyNumber=0, likeNumber=97, createdTime=2017-08-05, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=078de755107, moduleTitle=2015中国表皮生长因子受体基因敏感性突变和间变淋巴瘤激酶融合基因阳性非小细胞肺癌诊断治疗指南发布, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=078de755107)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1776009, encodeId=9ab61e760095a, content=<a href='/topic/show?id=b98d69614ae' target=_blank style='color:#2F92EE;'>#生长因子受体#</a>, objectTitle=2016中国非小细胞肺癌患者表皮生长因子受体基因突变检测专家共识发布, objectType=article, longId=76284, objectId=27d7e62840f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27d7e62840f, replyNumber=0, likeNumber=98, createdTime=2017-05-31, rootId=0, userName=cqlidoudou, userId=443c38859879, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27d7e62840f, moduleTitle=2016中国非小细胞肺癌患者表皮生长因子受体基因突变检测专家共识发布, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=27d7e62840f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生长因子受体

2020-05-29

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

JAMA Oncol：抗表皮生长因子受体抗体药物偶联物MRG003治疗晚期实体瘤

2022-10-05

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

Front Oncol：左侧RAS/BRAF野生型转移性结直肠癌(mCRC)患者一线抗表皮生长因子受体(EGFR)为基础治疗后后续维持治疗管理

2022-10-16

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

Eur Urol：继发于选择性成纤维细胞生长因子受体1-3抑制剂Infigratinib（BGJ398）的高磷血症与成纤维细胞生长因子受体3变异的晚期/转移性尿路癌的抗肿瘤疗效有关

2021-06-22

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

Breast Cancer Res Treat：Palbociclib加来曲唑作为雌激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌的一线治疗效果

2020-07-22

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

成纤维细胞生长因子受体（FGFR）抑制剂pemigatinib治疗胆管癌获得FDA的优先审查

2020-05-01

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关

2021-03-09

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

J Clin Oncol：辅助紫杉醇和曲妥珠单抗试验治疗结节阴性、人表皮生长因子受体2阳性乳腺癌的七年随访分析

2020-08-18

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

Nat Commun：揭示胰岛素样生长因子受体IGF1R激活的分子机制

2019-11-22

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

成纤维细胞生长因子受体酪氨酸激酶抑制剂E7090治疗胆管癌，获得日本厚生劳动省的Sakigake指定

2019-11-18

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

2019 CAP指南：乳腺癌人表皮生长因子受体2免疫组化定量分析

2019-10-20

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

Sci Rep：膀胱癌中组合光免疫疗法（PIT）靶向上皮生长因子受体（EGFR）和人类上皮生长因子受体2（HER2）研究

2019-08-04

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

Hepatology：肝星状细胞来源的血小板衍生生长因子受体α-丰富的细胞外小泡通过SHP2促进小鼠肝纤维化

2018-09-02

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

J Biol Chem：异位成纤维细胞生长因子受体1在前列腺癌细胞中能够促进炎症

2019-06-22

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

Diabetes：抑制肾上皮生长因子受体激活可延缓2型糖尿病肾病进展、改善胰岛素灵敏度

2018-12-16

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

Oncotarget：在预测TIG3膀胱癌结果中，人类表皮生长因子受体2表达比卡介苗处理更为重要

2018-01-22

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

Ophthalmologica：糖尿病黄斑水肿患者的眼房水中可溶性血管内皮生长因子受体(sVEGFR)和炎症因子的水平显著高于非糖尿病人！

2018-01-06

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

Gut：表皮生长因子受体抑制剂对幽门螺杆菌诱导上皮细胞炎症、DNA损伤及胃癌的预防

2018-01-09

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

2016EAU指南——血管内皮生长因子受体抵抗的肾脏透明细胞癌的靶向治疗发布

2017-04-12

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

2015中国表皮生长因子受体基因敏感性突变和间变淋巴瘤激酶融合基因阳性非小细胞肺癌诊断治疗指南发布

2017-08-05

cqlidoudou (审核中...)

前往app查看评论内容

#生长因子受体#

2016中国非小细胞肺癌患者表皮生长因子受体基因突变检测专家共识发布

2017-05-31

科室
- - 订阅+
  - 更多科室
工具
服务